Clinical and molecular complete remission in a case of variant hairy cell leukemia treated with DHAP followed by high-dose chemotherapy plus rituximab

Haematologica. 2004 Nov;89(11):ECR41.

Authors

Maria Goldaniga¹, Andrea Guffanti, Umberto Gianelli, Michele Magni, Giorgio Lambertenghi Deliliers, Luca Baldini

Affiliation

¹ Unità di Ematologia 1, Dipartimento di Ematologia ed Oncologia, Ospedale Maggiore IRCCS, Milan, Italy.

PMID: 15533846

No abstract available

Publication types

Case Reports

MeSH terms

Antibodies, Monoclonal / administration & dosage
Antibodies, Monoclonal / therapeutic use*
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Agents / administration & dosage
Antineoplastic Agents / therapeutic use
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Cisplatin / administration & dosage
Cisplatin / therapeutic use
Combined Modality Therapy
Cytarabine / administration & dosage
Cytarabine / therapeutic use
Dexamethasone / administration & dosage
Dexamethasone / therapeutic use
Humans
Leukemia, Hairy Cell / drug therapy*
Leukemia, Hairy Cell / genetics
Leukemia, Hairy Cell / therapy
Male
Middle Aged
Remission Induction
Rituximab
Stem Cell Transplantation

Substances

Antibodies, Monoclonal
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Agents
Cytarabine
Rituximab
Dexamethasone
Cisplatin

Supplementary concepts

DHAP protocol